Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Trinity Biotech PLC as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- 0 vs. Q1 2023
- Shares held
- 6.20M
- −118.9K (−1.9%) vs. Q1 2023
- Total value
- $5.93M
- −$33.4K (−0.6%) vs. Q1 2023
- New holders
- 4
- 1 more added
- Sold out
- 4
- 4 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRIB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $379.5K |
| Q1 2026 | 23 | $588.9K |
| Q4 2025 | 27 | $673.3K |
| Q3 2025 | 28 | $2.81M |
| Q2 2025 | 25 | $1.66M |
| Q1 2025 | 27 | $468.1K |
| Q4 2024 | 23 | $2.30M |
| Q3 2024 | 19 | $2.95M |
| Q2 2024 | 20 | $5.67M |
| Q1 2024 | 19 | $5.95M |
| Q4 2023 | 26 | $2.58M |
| Q3 2023 | 20 | $4.49M |
| Q2 2023 | 20 | $5.93M |
| Q1 2023 | 20 | $5.96M |
| Q4 2022 | 20 | $6.51M |
| Q3 2022 | 21 | $7.50M |
| Q2 2022 | 20 | $8.92M |
| Q1 2022 | 22 | $9.56M |
| Q4 2021 | 21 | $7.70M |
| Q3 2021 | 23 | $11.9M |
| Q2 2021 | 29 | $16.6M |
| Q1 2021 | 34 | $20.3M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Trinity Biotech PLC; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 4 | $4 | 0.00% | 00.0% | Unchanged |
| Atwood & Palmer Inc | 100 | $96 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 972 | $924 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,204 | $1.15K | 0.00% | 00.0% | Unchanged |
| CGC Financial Services, LLC | 1,500 | $1.43K | 0.00% | +1,500 | New |
| Rhumbline Advisers | 1,860 | $1.79K | 0.00% | +1,860 | New |
| Dynamic Advisor Solutions LLC | 10,000 | $9.51K | 0.00% | +10,000 | New |
| Group One Trading, L.P. | 16,691 | $16.1K | 0.00% | 00.0% | Unchanged |
| Redwood Wealth Management Group, LLC | 16,950 | $16.1K | 0.02% | 00.0% | Unchanged |
| State of New Jersey Common Pension Fund D | 27,062 | $26.1K | 0.00% | 00.0% | Unchanged |
| Wealthsource Partners, LLC | 30,200 | $28.7K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 37,622 | $36.3K | 0.00% | +15,351+68.9% | Added |
| Morgan Stanley | 38,233 | $36.4K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 111,400 | $106.0K | 0.00% | +111,400 | New |
| Aristides Capital LLC | 162,317 | $154.4K | 0.09% | 00.0% | Unchanged |
| Whitefort Capital Management, LP | 409,517 | $389.5K | 0.37% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 727,954 | $701.0K | 0.00% | −14,600−2.0% | Reduced |
| Renaissance Technologies LLC | 1,372,798 | $1.31M | 0.00% | −4,100−0.3% | Reduced |
| Stonehill Capital Management LLC | 1,512,975 | $1.44M | 1.58% | −75,000−4.7% | Reduced |
| Hunter Associates Investment Management LLC | 1,724,000 | $1.66M | 0.32% | −51,100−2.9% | Reduced |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −53,099−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −34,300−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −14,684−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −12,092−100.0% | Sold out |